Centrum Medyczne ENEL-MED S.A. (WSE: ENE)
Poland
· Delayed Price · Currency is PLN 19.90
0.00 (0.00%)
Nov 21, 2024, 9:01 AM CET
Centrum Medyczne ENEL-MED Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 680.32 | 618.55 | 494.9 | 441.14 | 399.8 | 417.69 | Upgrade
|
| Revenue | 680.32 | 618.55 | 494.9 | 441.14 | 399.8 | 417.69 | Upgrade
|
| Revenue Growth (YoY) | 25.43% | 24.98% | 12.19% | 10.34% | -4.28% | 12.37% | Upgrade
|
| Cost of Revenue | 641.41 | 592.59 | 484.02 | 419 | 369.5 | 394.09 | Upgrade
|
| Gross Profit | 38.91 | 25.96 | 10.88 | 22.14 | 30.3 | 23.6 | Upgrade
|
| Selling, General & Admin | 33.76 | 33.51 | 37.12 | 23.82 | 20.23 | 20.24 | Upgrade
|
| Other Operating Expenses | -4.54 | -9.11 | -6.54 | -3.73 | -3.3 | -0.34 | Upgrade
|
| Operating Expenses | 29.23 | 24.4 | 30.58 | 20.09 | 16.93 | 19.9 | Upgrade
|
| Operating Income | 9.68 | 1.56 | -19.7 | 2.06 | 13.37 | 3.7 | Upgrade
|
| Interest Expense | -17.06 | -9.9 | -5.82 | -5.33 | -7.52 | -7.01 | Upgrade
|
| Interest & Investment Income | - | 1.82 | 2.46 | 1.64 | 1.09 | 0.72 | Upgrade
|
| Currency Exchange Gain (Loss) | 16.65 | 16.65 | -2.83 | 0.61 | -9.98 | 1.77 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.01 | -0.01 | -0.03 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | 9.26 | 10.11 | -25.89 | -1.03 | -3.07 | -0.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.04 | -0.04 | -0.77 | - | -3.24 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.34 | -3.34 | -1.28 | -0.1 | -0.97 | -0.16 | Upgrade
|
| Legal Settlements | -0.04 | -0.04 | - | -0.02 | -0 | -0.01 | Upgrade
|
| Other Unusual Items | 3.13 | 3.13 | - | 1.24 | 2.8 | - | Upgrade
|
| Pretax Income | 8.96 | 9.81 | -27.94 | 0.1 | -4.48 | -1.02 | Upgrade
|
| Income Tax Expense | 1.98 | 1.58 | -4.38 | 1.51 | -1.08 | 1.45 | Upgrade
|
| Earnings From Continuing Operations | 6.98 | 8.23 | -23.56 | -1.41 | -3.4 | -2.47 | Upgrade
|
| Net Income | 6.98 | 8.23 | -23.56 | -1.41 | -3.4 | -2.47 | Upgrade
|
| Net Income to Common | 6.98 | 8.23 | -23.56 | -1.41 | -3.4 | -2.47 | Upgrade
|
| Net Income Growth | 4.07% | - | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 28 | 28 | 28 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 28 | 28 | 24 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | 0.18% | - | 17.55% | 2.08% | - | - | Upgrade
|
| EPS (Basic) | 0.25 | 0.29 | -0.83 | -0.06 | -0.14 | -0.10 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.29 | -0.83 | -0.06 | -0.14 | -0.10 | Upgrade
|
| EPS Growth | 3.88% | - | - | - | - | - | Upgrade
|
| Free Cash Flow | 45.18 | 48.26 | -5.9 | 28.55 | 63.44 | 45.44 | Upgrade
|
| Free Cash Flow Per Share | 1.60 | 1.71 | -0.21 | 1.19 | 2.69 | 1.93 | Upgrade
|
| Gross Margin | 5.72% | 4.20% | 2.20% | 5.02% | 7.58% | 5.65% | Upgrade
|
| Operating Margin | 1.42% | 0.25% | -3.98% | 0.47% | 3.34% | 0.89% | Upgrade
|
| Profit Margin | 1.03% | 1.33% | -4.76% | -0.32% | -0.85% | -0.59% | Upgrade
|
| Free Cash Flow Margin | 6.64% | 7.80% | -1.19% | 6.47% | 15.87% | 10.88% | Upgrade
|
| EBITDA | 17.09 | 30.09 | 5.53 | 24.79 | 35.69 | 26.06 | Upgrade
|
| EBITDA Margin | 2.51% | 4.86% | 1.12% | 5.62% | 8.93% | 6.24% | Upgrade
|
| D&A For EBITDA | 7.41 | 28.54 | 25.22 | 22.73 | 22.33 | 22.36 | Upgrade
|
| EBIT | 9.68 | 1.56 | -19.7 | 2.06 | 13.37 | 3.7 | Upgrade
|
| EBIT Margin | 1.42% | 0.25% | -3.98% | 0.47% | 3.34% | 0.89% | Upgrade
|
| Effective Tax Rate | 22.06% | 16.12% | - | 1568.75% | - | - | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 417.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.